Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncologyMichelino De Laurentiis, Sabino De Placido, Giuseppe Cancello et al.|Annals of Oncology|2005Cited by 49
The COVID - AGICT study: COVID–19 and advanced gastro-intestinal cancer surgical treatment. A multicentric Italian study on the SARS-CoV-2 pandemic impact on gastro-intestinal cancers surgical treatment during the 2020. Analysis of perioperative and short-term oncological outcomesGiuseppe Giuliani, Jacopo Andreuccetti, Lucia Salvischiani et al.|Surgical Oncology|2023Cited by 6